Mayne Pharma International Pty Ltd, 10% Owner at HedgePath Pharmaceuticals, Inc. (HPPI), bought 600,000 shares at $0.27 ($163K) on 2017-12-19, disclosed to the SEC on 2018-02-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.